Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
sandretto building, cavalry hill industrial park, northampton, NN7 4PP
Website
-
liqmeds worldwide limitedEstimated Valuation
£9m
Pomanda estimates the enterprise value of LIQMEDS WORLDWIDE LIMITED at £9m based on a Turnover of £11.9m and 0.76x industry multiple (adjusted for size and gross margin).
liqmeds worldwide limitedEstimated Valuation
£13.8m
Pomanda estimates the enterprise value of LIQMEDS WORLDWIDE LIMITED at £13.8m based on an EBITDA of £2.7m and a 5.18x industry multiple (adjusted for size and gross margin).
liqmeds worldwide limitedEstimated Valuation
£5.5m
Pomanda estimates the enterprise value of LIQMEDS WORLDWIDE LIMITED at £5.5m based on Net Assets of £2.4m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Liqmeds Worldwide LimitedOverview
Liqmeds Worldwide Limited is a live company located in northampton, NN7 4PP with a Companies House number of 09999498. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in February 2016, it's largest shareholder is
zydus pharmaceuticals uk ltd
with a 100% stake. Liqmeds Worldwide Limited is a young,
mid sized company, Pomanda has estimated its turnover at
£11.9m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Liqmeds Worldwide Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
5 Strong
3 Regular
3 Weak
Size
annual sales of £11.9m, make it larger than the average company (£1.7m)
£11.9m - Liqmeds Worldwide Limited
£1.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 123%, show it is growing at a faster rate (8.5%)
123% - Liqmeds Worldwide Limited
8.5% - Industry AVG
Production
with a gross margin of 46%, this company has a comparable cost of product (46%)
46% - Liqmeds Worldwide Limited
46% - Industry AVG
Profitability
an operating margin of 22.4% make it more profitable than the average company (5.5%)
22.4% - Liqmeds Worldwide Limited
5.5% - Industry AVG
Employees
with 107 employees, this is above the industry average (17)
107 - Liqmeds Worldwide Limited
17 - Industry AVG
Pay Structure
on an average salary of £48.4k, the company has an equivalent pay structure (£48.4k)
£48.4k - Liqmeds Worldwide Limited
£48.4k - Industry AVG
Efficiency
resulting in sales per employee of £111.3k, this is equally as efficient (£112k)
£111.3k - Liqmeds Worldwide Limited
£112k - Industry AVG
Debtor Days
it gets paid by customers after 74 days, this is later than average (53 days)
74 days - Liqmeds Worldwide Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (32 days)
5 days - Liqmeds Worldwide Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Liqmeds Worldwide Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 16 weeks, this is less cash available to meet short term requirements (29 weeks)
16 weeks - Liqmeds Worldwide Limited
29 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 32.5%, this is a lower level of debt than the average (51.5%)
32.5% - Liqmeds Worldwide Limited
51.5% - Industry AVG
LIQMEDS WORLDWIDE LIMITED financials
EXPORT
Liqmeds Worldwide Limited's latest turnover from March 2024 is estimated at £11.9 million and the company has net assets of £2.4 million. According to their latest financial statements, we estimate that Liqmeds Worldwide Limited has 107 employees and maintains cash reserves of £383.5 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Nov 2023
Dec 2022
Aug 2022
Aug 2021
Aug 2020
Feb 2019
Feb 2018
Feb 2017
Turnover
11,913,313
5,794,330
1,371,894
1,461,246
1,081,229
1,590,027
935,107
1,012,693
Other Income Or Grants
Cost Of Sales
6,433,723
3,227,393
779,191
815,478
597,985
880,389
490,336
531,082
Gross Profit
5,479,590
2,566,937
592,703
645,768
483,243
709,638
444,771
481,611
Admin Expenses
2,813,520
2,646,483
531,670
633,201
140,875
534,473
443,409
450,311
Operating Profit
2,666,070
-79,546
61,033
12,567
342,368
175,165
1,362
31,300
Interest Payable
Interest Receivable
22,434
12,946
424
68
3
8
42
Pre-Tax Profit
2,688,504
-66,600
61,457
12,635
342,372
175,173
1,404
31,300
Tax
-672,126
-11,677
-2,401
-65,051
-33,283
-267
-5,947
Profit After Tax
2,016,378
-66,600
49,780
10,234
277,321
141,890
1,137
25,353
Dividends Paid
Retained Profit
2,016,378
-66,600
49,780
10,234
277,321
141,890
1,137
25,353
Employee Costs
5,180,583
2,491,143
561,705
649,188
492,890
650,526
397,398
436,076
Number Of Employees
107
50
11
14
11
15
9
10
EBITDA*
2,666,070
-79,546
61,033
12,567
342,368
175,165
1,362
31,300
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Nov 2023
Dec 2022
Aug 2022
Aug 2021
Aug 2020
Feb 2019
Feb 2018
Feb 2017
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
2,438,321
1,282,349
288,000
315,755
181,871
186,874
178,123
Group Debtors
360,701
Misc Debtors
439,926
1,576,411
1,120,371
1,114,903
561,857
356,946
193,718
25,000
Cash
383,510
471,112
22,073
5,607
2,157
4,700
11,052
100
1
misc current assets
total current assets
3,622,458
3,329,872
1,430,444
1,436,265
745,885
548,520
204,770
203,223
1
total assets
3,622,458
3,329,872
1,430,444
1,436,265
745,885
548,520
204,770
203,223
1
Bank overdraft
Bank loan
Trade Creditors
88,408
60,529
50,550
53,759
138,263
350,692
176,100
150,000
Group/Directors Accounts
545,672
other short term finances
hp & lease commitments
other current liabilities
543,019
2,840,362
884,313
926,471
161,821
29,348
2,080
27,770
total current liabilities
1,177,099
2,900,891
934,863
980,230
300,084
380,040
178,180
177,770
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
1,177,099
2,900,891
934,863
980,230
300,084
380,040
178,180
177,770
net assets
2,445,359
428,981
495,581
456,035
445,801
168,480
26,590
25,453
1
total shareholders funds
2,445,359
428,981
495,581
456,035
445,801
168,480
26,590
25,453
1
Mar 2024
Nov 2023
Dec 2022
Aug 2022
Aug 2021
Aug 2020
Feb 2019
Feb 2018
Feb 2017
Operating Activities
Operating Profit
2,666,070
-79,546
61,033
12,567
342,368
175,165
1,362
31,300
Depreciation
Amortisation
Tax
-672,126
-11,677
-2,401
-65,051
-33,283
-267
-5,947
Stock
Debtors
380,188
1,450,389
664,643
686,930
199,908
350,102
-9,405
203,123
Creditors
27,879
9,979
-87,713
-84,504
-212,429
174,592
26,100
150,000
Accruals and Deferred Income
-2,297,343
1,956,049
722,492
764,650
132,473
27,268
-25,690
27,770
Deferred Taxes & Provisions
Cash flow from operations
-655,708
436,093
19,492
3,382
-2,547
-6,360
10,910
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
545,672
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
99
1
interest
22,434
12,946
424
68
3
8
42
cash flow from financing
568,106
12,946
424
68
3
8
42
99
1
cash and cash equivalents
cash
-87,602
449,039
19,916
3,450
-2,543
-6,352
10,952
99
1
overdraft
change in cash
-87,602
449,039
19,916
3,450
-2,543
-6,352
10,952
99
1
liqmeds worldwide limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for liqmeds worldwide limited. Get real-time insights into liqmeds worldwide limited's credit score, group structure and payment trends.
Perform a competitor analysis for liqmeds worldwide limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in NN7 area or any other competitors across 12 key performance metrics.
liqmeds worldwide limited Ownership
LIQMEDS WORLDWIDE LIMITED group structure
Liqmeds Worldwide Limited has no subsidiary companies.
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
February 2016
age
9
incorporated
UK
ultimate parent company
ZYDUS LIFESCIENCES LTD
accounts
Small Company
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
THE CORPORATE PRACTICE LIMITED
address
sandretto building, cavalry hill industrial park, northampton, NN7 4PP
Bank
-
Legal Advisor
-
liqmeds worldwide limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to liqmeds worldwide limited.
liqmeds worldwide limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for LIQMEDS WORLDWIDE LIMITED. This can take several minutes, an email will notify you when this has completed.
liqmeds worldwide limitedCompanies House Filings - See Documents
